Legacy Feeds NC's Resilient Life Sciences Supply Chain Growth

By Jim Shamp, NC Biotech

North Carolina’s rise as a global life sciences powerhouse is rooted in decades of supply‑chain strength. Today, that foundation is fueling record‑setting growth. More than $16 billion in announced investments since 2024, a 76,000‑strong workforce, and a network of over 860 companies reflect a mature ecosystem built for complex, regulated industries. Across the state, capabilities span biomanufacturing, R&D, contract services, cold‑chain logistics, policy expertise, and multimodal transportation—supported by deep‑water ports, expanding airports, Class I rail lines, and 90,000 miles of highway. New developments such as GXP‑Storage’s headquarters in Middlesex and Frontier Scientific Solutions’ massive GMP-certified logistics hub in Wilmington underscore the state’s shift toward highly specialized, temperature‑controlled infrastructure essential for biologics, cell therapies, and agtech materials.

Together, these assets position North Carolina as one of the world’s most integrated, future‑ready life sciences supply chain environments. Access the full article to see how this ecosystem is shaping global industry momentum.